Clinical Trial Update: Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013) [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of adding oral roflumilast to low-dose inhaled corticosteroids in asthma patients aged 12-70; the study has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED